Chemomab Therapeutics Ltd. News

Latest Chemomab Therapeutics Ltd. Stock News & CMMB Headlines

Chemomab Therapeutics and Scipher Medicine Announce SEC Registration Statement on Form S-4 Is Effective

14 days ago | globenewswire.com

Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update

3 months ago | globenewswire.com

Chemomab Therapeutics Ltd. (CMMB) M&A Call Prepared Remarks Transcript

4 months ago | seekingalpha.com

Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis

4 months ago | globenewswire.com

Chemomab Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update

6 months ago | globenewswire.com

Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update

8 months ago | globenewswire.com

Chemomab Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference

9 months ago | globenewswire.com

Chemomab Therapeutics Ltd. Sponsored ADR (NASDAQ:CMMB) Sees Significant Growth in Short Interest

10 months ago | defenseworld.net

Chemomab Therapeutics Announces Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis Published in the American Journal of Gastroenterology

a year ago | globenewswire.com

Chemomab to Participate in Oppenheimer's Movers in Rare Disease Summit

a year ago | globenewswire.com

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

Market Closed

CMMB

Chemomab Therapeutics Ltd.

$ 1.53

9.29%

Last 24H

Trading with leverage comes with a high risk and may not be suitable for everyone.

Portfolio

Updated 2 days ago

Top

Gainers

Losers

Symbol

Last Price

24H CNG

Chemomab Therapeutics Ltd. News

Latest Chemomab Therapeutics Ltd. Stock News & CMMB Headlines

Download App

People Also Watch

Explore our Tools